search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Marked radiation reduction in mammography investigated.


- candidate number8920
- NTR NumberNTR2687
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR12-jan-2011
- Secondary IDs1019 / NL32234.008.10 METC Elisabeth ZHS / CCMO
- Public TitleMarked radiation reduction in mammography investigated.
- Scientific TitleHow do very low dose images in digital mammography compare to regular dose images?
A ‘proof-of-principle’ study on diagnostic performance and physical image quality
- ACRONYMDOSE TRIAL
- hypothesisPerforming mammography with only a full radiation dose mediolateral oblique (MLO) view and all additional views obtained with a markedly reduced dose will not significantly affect the diagnostic accuracy of digital mammography.
- Healt Condition(s) or Problem(s) studiedBreast cancer, Dosimetry, Digital mammography
- Inclusion criteria1. Female;
2. Age > 30 years;
3. Scheduled mammography;
4. Every clinical indication;
5. Every ethnicity.
- Exclusion criteria1. No informed consent;
2. Male;
3. Age < 30 years;
4. Pregnancy;
5. Lactation;
6. Extreme mastodynia (breast pain);
7. Physical conditions that restrict mammography assessment (e.g. paralysis, stiffness, etc.).
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-okt-2010
- planned closingdate1-okt-2011
- Target number of participants400
- InterventionsAdditional low-dose mammographic views.
- Primary outcome1. Detection rate;
2. Subjective diagnostic quality (by radiologists);
3. Image quality (by physico-technical methods).
- Secondary outcome1. Image noise (by radiologists);
2. BIRADS category;
3. Need for additional imaging;
4. Lesion type (in case of visible pathology).
- TimepointsAll results are to be expected in one year.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES A.M.J. Bleukens
- CONTACT for SCIENTIFIC QUERIES A.M.J. Bleukens
- Sponsor/Initiator Landelijk ReferentieCentrum voor Bevolkingsonderzoek (LRCB)
- Funding
(Source(s) of Monetary or Material Support)
Nuts/Ohra
- PublicationsN/A
- Brief summaryRationale:
With the incidence of breast cancer still rising we see an increasing number of women, irrespective of age, undergo an also increasing amount of mammographic examinations for varying purposes. However, mammography is associated with ionising radiation and every mammogram adds to a woman’s life-time radiation exposure with subsequent risks.
Due to the possibilities of tailored image processing in digital mammography, reducing radiation dosage, while preserving diagnostic performance, is more realistic than ever before. Thus far only phantom studies have been performed in this field and the relationship between physical image quality measures and diagnostic performance is poorly understood.
Outcomes of our pilot study with mastectomy specimens suggest a possible 80% dose reduction in mammographic images in real practice. We therefore hypothesise that performing mammography with only a full radiation dose mediolateral oblique (MLO) view and all additional views obtained with a markedly reduced dose will not significantly affect the diagnostic accuracy of digital mammography. Obtaining low-dose images in addition to a high-dose MLO decreases life-time exposure to radiation and might contribute to breast cancer detection by lowering the threshold for obtaining additional images in the diagnostic as well as the screening setting.

Objective:
To investigate the clinical diagnostic performance of (extremely) low-dose views in standard digital mammography and relate this to physical image quality measures. Our study will aim:
1. To determine the effect of low dose images on the subjective rating of image quality and diagnostic performance by a number of independent radiologists;
2. To quantify image quality of low-dose and standard dose views in digital mammography using physico-technical methods;
3. To relate this information to results from technical quality control measurements.

Study design:
We propose an observational performance (proof-of-principle) study in the hospital setting. In addition to a standard clinical mammogram (MLO and craniocaudal (CC) view) a low-dose CC-view will be performed. Both exam combinations (MLO & low-dose CC, and MLO & full dose CC) will be interpreted independently by three experienced radiologists. Differences in clinical outcome will be analysed in order to determine the diagnostic performance of low-dose CC images in digital mammography. These clinical results will further be related to objective physico-technical measurements of image quality.

Study population:
Women older than 30 years having mammography performed in our hospital (St. Elisabeth), irrespective of medical complaints or history.

Main study parameters/endpoints:
Primary: Pathology detection, diagnostic quality (subjective), image quality (objective).
Secondary: Lesion type, BIRADS category, need for additional imaging, image noise.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
There is no direct risk in participating, since it encompasses a known and standardised diagnostic procedure. However, the extended procedure does come with lengthening of breast compression time and possible physical discomfort. Since a markedly reduced dose is used for the additional study images associated indirect (stochastic) effects of additional radiation images might be negligible. Analysing the potential of radiation reduction in a widely and frequently used procedure such as mammography may benefit the entire female population, and therefore the participant as well in case of future mammography examinations.
- Main changes (audit trail)
- RECORD12-jan-2011 - 28-jan-2011


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl